Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
12,475,677
-
Share change
-
+358,915
-
Total reported value
-
$397,091,901
-
Put/Call ratio
-
108%
-
Price per share
-
$31.83
-
Number of holders
-
135
-
Value change
-
+$11,089,244
-
Number of buys
-
65
-
Number of sells
-
61
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q3 2015
As of 30 Sep 2015,
Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,475,677 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, THOMPSON SIEGEL & WALMSLEY LLC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, BTIM Corp., LOMBARDIA CAPITAL PARTNERS LLC, Portolan Capital Management, LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., and Cove Street Capital, LLC.
This page lists
135
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.